Aquablation therapy is associated with 3-year outcomes similar to those of transurethral resection of the prostate (TURP) for the treatment of lower urinary tract symptoms related to benign prostatic hyperplasia (BPH), according to a new study. At 3 years, men who underwent Aquablation—a minimally invasive procedure in which a high-velocity waterjet is used to resect…
Neutrophil-to-lymphocyte ratio (NLR) may be useful as a surrogate marker of intravesical prostatic protrusion (IPP) in men with benign prostatic hyperplasia, according to a new report. IPP is an anatomical feature caused by the growth of prostatic lateral and median lobes. The new finding is from a study of 250 men older than 50 years…
Prostate calcifications in men with benign prostatic hyperplasia are associated with nearly 3-fold increased odds of storage lower urinary tract symptoms and nocturia, a study found.
Men who have bladder outlet obstruction (BOO) prior to robotic-assisted radical prostatectomy experience significant worsening of lower urinary tract function compared with men without BOO, a study found.
In a prospective trial of men with erectile dysfunction and lower urinary tract symptoms, tadalafil plus tamsulosin achieved greater improvements in maximum urinary flow rates and voiding symptoms.
Post-marketing data show that prostatic urethral lift provides symptom relief in patients outside of the controlled clinical trial setting.
LUTS treatment with the alpha-blocker prazosin was associated with significantly lower 2- and 5-year biochemical recurrence rates vs tamsulosin and non-use of alpha-blockers.
Lower urinary tract symptom severity in men is associated with detectable bacteria in urine obtained via catheter, new study suggests.
Significant improvements in symptoms, peak flow rate, and post-void residual volume observed in men with prostate volumes of 80 to 150 cc.
Women presenting with lower urinary tract symptoms cluster into 4 distinct symptom groups, according to a recent study.
